Zbigniew Gugala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zbigniew Gugala has a total of 281 co-authors. Here are the top co-authors by number of shared publications:
- Yi-Hsuan Wu
Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas
30 shared publications - Xiang H.-F. Zhang
Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA
29 shared publications - Hai Wang
Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, USA
28 shared publications Ronald W. Lindsey
Department of Orthopaedic Surgery and Rehabilitation, The University of Texas Medical Branch, Galveston, TX, USA
27 shared publications- Yichao Shen
Integrative Molecular and Biomedical Sciences Graduate Program, Baylor College of Medicine, Houston, Texas
26 shared publications - David G. Edwards
Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas
25 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in Nature Communications
A lactate-fatty acid loop drives prostate cancer bone colonization by mediating metabolic interplay between tumor cells and osteoblasts
Bone metastasis is the major cause of morbidity and mortality in advanced prostate cancer, yet current therapies provide only limited clinical benefit. Here, we show that prostate cancer cells metabolically adapt to the bone microenvironment by utilizing bone-cell-derived lactate as an alternative nutrient source. Beyond fueling oxidative phosphorylation, lactate serves as carbon source for fatty acid synthesis. Among the resulting lipid products, oleic acid is secreted to reward osteoblast, establishing a reciprocal metabolic interplay that supports both tumor progression and pathological bone formation. Mechanistically, we identify MCT1 as the essential transporter mediating lactate uptake in bone-colonizing tumor cells. MCT1 expression is coordinately regulated by NFAT signaling and extracellular glucose availability at both transcriptional and post-translational levels. Genetic deletion and pharmacological inhibition of MCT1 markedly suppresses prostate tumor growth in bone. Together, these findings uncover a lactate-driven metabolic crosstalk, identifying MCT1 as a promising therapeutic target for prostate cancer bone metastasis.
- 10 November 2026
- Published by Springer Nature in Nature Communications
Open AccessA lactate-fatty acid loop drives prostate cancer bone colonization by mediating metabolic interplay between tumor cells and osteoblasts
Bone metastasis is the major cause of morbidity and mortality in advanced prostate cancer, yet current therapies provide only limited clinical benefit. Here, we show that prostate cancer cells metabolically adapt to the bone microenvironment by utilizing bone-cell-derived lactate as an alternative nutrient source. Beyond fueling oxidative phosphorylation, lactate serves as carbon source for fatty acid synthesis. Among the resulting lipid products, oleic acid is secreted to reward osteoblast, establishing a reciprocal metabolic interplay that supports both tumor progression and pathological bone formation. Mechanistically, we identify MCT1 as the essential transporter mediating lactate uptake in bone-colonizing tumor cells. MCT1 expression is coordinately regulated by NFAT signaling and extracellular glucose availability at both transcriptional and post-translational levels. Genetic deletion and pharmacological inhibition of MCT1 markedly suppresses prostate tumor growth in bone. Together, these findings uncover a lactate-driven metabolic crosstalk, identifying MCT1 as a promising therapeutic target for prostate cancer bone metastasis.
- Open Access
Enhanced Metabolic Risks in Patients with Obesity and Nutritional Deficiencies in the U.S.: A TriNetX Study
Background/Objectives: Nutrient deficiencies associated with progression from obesity to metabolic dysfunction are poorly characterized. Using electronic health records (TriNetX Research Network), we evaluated the association between key nutritional deficiencies and metabolic outcomes among patients with obesity. Methods: Deficiencies assessed included protein–energy malnutrition, deficiencies in vitamin D, calcium, magnesium, and vitamin B12, and prior underweight status. Outcomes included severe obesity, prediabetes, type 2 diabetes, metabolic syndrome, metabolic dysfunction-associated steatotic liver disease (MASLD), and metabolic dysfunction-associated steatohepatitis (MASH). After matching propensity scores, cohorts with the double burden of malnutrition (DBM) were compared with a reference cohort of patients with obesity but no history of nutritional deficiencies. Results: The most prevalent types of DBM were vitamin D deficiency (10.6%), protein deficiency (8.9%) and calcium deficiency (7.5%). Incidence rates of obesity and all types of DBM increased from 2023 to 2025. Although middle-aged White and Black/African American patients represented the largest demographic groups, adults aged >70 years exhibited higher incidence rates of protein, calcium, magnesium, and B12 deficiencies. Vitamin D deficiency (median hazard ratio [HR] 3.09; IQR 2.32–5.66), vitamin B12 deficiency (median HR 2.49; IQR 2.16–6.08), and prior underweight (median HR 2.23; IQR 1.76–3.98) were associated with the highest burden of metabolic diseases. Conclusions: These findings underscore the interplay between nutritional deficiencies and metabolic disease risk in obesity and support targeted interventions for populations affected by DBM, especially older adults, and in the context of racial and socioeconomic disparities.
Open AccessEnhanced Metabolic Risks in Patients with Obesity and Nutritional Deficiencies in the U.S.: A TriNetX Study
Background/Objectives: Nutrient deficiencies associated with progression from obesity to metabolic dysfunction are poorly characterized. Using electronic health records (TriNetX Research Network), we evaluated the association between key nutritional deficiencies and metabolic outcomes among patients with obesity. Methods: Deficiencies assessed included protein–energy malnutrition, deficiencies in vitamin D, calcium, magnesium, and vitamin B12, and prior underweight status. Outcomes included severe obesity, prediabetes, type 2 diabetes, metabolic syndrome, metabolic dysfunction-associated steatotic liver disease (MASLD), and metabolic dysfunction-associated steatohepatitis (MASH). After matching propensity scores, cohorts with the double burden of malnutrition (DBM) were compared with a reference cohort of patients with obesity but no history of nutritional deficiencies. Results: The most prevalent types of DBM were vitamin D deficiency (10.6%), protein deficiency (8.9%) and calcium deficiency (7.5%). Incidence rates of obesity and all types of DBM increased from 2023 to 2025. Although middle-aged White and Black/African American patients represented the largest demographic groups, adults aged >70 years exhibited higher incidence rates of protein, calcium, magnesium, and B12 deficiencies. Vitamin D deficiency (median hazard ratio [HR] 3.09; IQR 2.32–5.66), vitamin B12 deficiency (median HR 2.49; IQR 2.16–6.08), and prior underweight (median HR 2.23; IQR 1.76–3.98) were associated with the highest burden of metabolic diseases. Conclusions: These findings underscore the interplay between nutritional deficiencies and metabolic disease risk in obesity and support targeted interventions for populations affected by DBM, especially older adults, and in the context of racial and socioeconomic disparities.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figures from Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer
Supplementary Figure 1 Shows the distribution of ERBB2 mutations among metastatic cancer patients, survival outcomes according to metastatic sites (bone vs visceral), and detailed CTC counts from HR+/Her2- MBC patients. Supplementary Figure 2 Shows the therapeutic effect of Tras-ALN on metastasis spread from bone metastasis models of HR+ breast cancer via uCT, live and ex vivo bioluminescence profiling of metastatic organs. Supplementary Figure 3 shows the increased expression of ERBB2 in MSC 3D coculture and anti-ER treatment conditions. Supplementary Figure 4 shows the immune-independent effect of Tras-ALN in blocking metastasis progression. Supplementary Figure 5 shows that direct cell-cell interaction is not required for MSC-induced Her2 expression based on 3D transwell culture conditions. Supplementary 1 of Figure 6 shows genetic modulations of Her2 (ERBB2) in MCF7 and ZR75-1 breast cancer models. Supplementary 2 of Figure 6 shows that genetic alteration of Her2 impacts multiorgan metastasis seeding in HR+ breast cancer models. Supplementary 1 of Figure 7 shows that miRNAs with Her2 targeting potential are associated with overall survival in breast cancer. Supplementary 2 of Figure 7 shows that miR-133a/b abrogates brain metastasis seeding from bone-derived ZR75-1 cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures from Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2− Breast Cancer
Supplementary Figure 1 Shows the distribution of ERBB2 mutations among metastatic cancer patients, survival outcomes according to metastatic sites (bone vs visceral), and detailed CTC counts from HR+/Her2- MBC patients. Supplementary Figure 2 Shows the therapeutic effect of Tras-ALN on metastasis spread from bone metastasis models of HR+ breast cancer via uCT, live and ex vivo bioluminescence profiling of metastatic organs. Supplementary Figure 3 shows the increased expression of ERBB2 in MSC 3D coculture and anti-ER treatment conditions. Supplementary Figure 4 shows the immune-independent effect of Tras-ALN in blocking metastasis progression. Supplementary Figure 5 shows that direct cell-cell interaction is not required for MSC-induced Her2 expression based on 3D transwell culture conditions. Supplementary 1 of Figure 6 shows genetic modulations of Her2 (ERBB2) in MCF7 and ZR75-1 breast cancer models. Supplementary 2 of Figure 6 shows that genetic alteration of Her2 impacts multiorgan metastasis seeding in HR+ breast cancer models. Supplementary 1 of Figure 7 shows that miRNAs with Her2 targeting potential are associated with overall survival in breast cancer. Supplementary 2 of Figure 7 shows that miR-133a/b abrogates brain metastasis seeding from bone-derived ZR75-1 cells.
- Open Access
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 330 (6) , E813-E829
Undernutrition-related diabetes in mice is linked to early undernutrition
Early-life undernutrition plays a critical role in the development of undernutrition-related diabetes. Undernourished mice exhibited a metabolic shift from the glucose metabolism toward the fatty acid metabolism, leading to bone fragility and hepatic steatosis. Paradoxically, undernutrition-related diabetes emerged after transition to a regular diet due to a persistent compromised insulin production and impaired pancreatic catch-up growth. Early-life undernutrition is a pivotal contributor to metabolic disorders and comorbidities in populations facing the double burden of malnutrition.
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 330 (6) , E813-E829
Open AccessUndernutrition-related diabetes in mice is linked to early undernutrition
Early-life undernutrition plays a critical role in the development of undernutrition-related diabetes. Undernourished mice exhibited a metabolic shift from the glucose metabolism toward the fatty acid metabolism, leading to bone fragility and hepatic steatosis. Paradoxically, undernutrition-related diabetes emerged after transition to a regular diet due to a persistent compromised insulin production and impaired pancreatic catch-up growth. Early-life undernutrition is a pivotal contributor to metabolic disorders and comorbidities in populations facing the double burden of malnutrition.
- 29 May 2026
- Published by Elsevier in Cancer Letters
- Vol. 655, 218636
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis
- 29 May 2026
- Published by Elsevier in Cancer Letters
- Vol. 655, 218636
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis
- 27 March 2026
- Published by Bentham Science Publishers Ltd. in Current Science, Engineering and Technology
- Vol. 06
Operating Room Personnel’s Perception of Surgical Smoke Inhalation as a Health Hazard: A Systematic Review
Background: Surgical smoke, generated by energy-based instruments such as electrocautery and lasers, poses significant health risks to operating room (OR) personnel. Despite these dangers, awareness and mitigation practices remain inconsistent across healthcare settings. Methods: A literature search of PubMed/MEDLINE, Cochrane Library, JSTOR, Scopus, CINAHL, and Ovid was conducted, adhering to PRISMA guidelines. Inclusion criteria focused on studies utilizing questionnaires to evaluate awareness and protective equipment use among OR personnel. Primary outcomes of interest included OR personnel’s awareness of surgical smoke hazards and the preventative measures in place to limit their exposure. Secondary outcomes included institutional policies and hazard education for the at-risk population. Data extraction and risk of bias assessments were performed independently by two reviewers. Results: From 3,194 articles, 27 full-text articles were reviewed, resulting in the inclusion of 10 studies comprising 4,409 OR personnel responses from seven different countries. More perioperative nurses were surveyed than any other OR personnel. Significant disparities were found in awareness and protective measures. Perioperative nurses demonstrated higher awareness than surgeons and anesthetists, who exhibited lower awareness and inconsistent use of protective measures. Hazard education was the primary predictor for surgical smoke hazard awareness and protective equipment usage. The evident exclusion of trainees, such as medical students and residents, from included surveys underscores a notable gap in research for personnel at risk of future exposure to the occupational hazards of surgical smoke. Discussion: This review demonstrates substantial variability in awareness and protective practices regarding surgical smoke among OR personnel. Perioperative nurses consistently exhibited greater awareness than surgeons and anesthetists, who, despite higher direct exposure, reported lower knowledge and inconsistent use of protective measures. The exclusion of trainees represents a critical deficiency, as early education is vital for fostering safe, long-term practices. Conclusion: These findings underscore the need for standardized training programs and comprehensive institutional policies to improve awareness and ensure consistent adoption of protective measures. Enhanced safety protocols are essential to safeguard OR personnel and ultimately improve patient care outcomes.
- 27 March 2026
- Published by Bentham Science Publishers Ltd. in Current Science, Engineering and Technology
- Vol. 06
Operating Room Personnel’s Perception of Surgical Smoke Inhalation as a Health Hazard: A Systematic Review
Background: Surgical smoke, generated by energy-based instruments such as electrocautery and lasers, poses significant health risks to operating room (OR) personnel. Despite these dangers, awareness and mitigation practices remain inconsistent across healthcare settings. Methods: A literature search of PubMed/MEDLINE, Cochrane Library, JSTOR, Scopus, CINAHL, and Ovid was conducted, adhering to PRISMA guidelines. Inclusion criteria focused on studies utilizing questionnaires to evaluate awareness and protective equipment use among OR personnel. Primary outcomes of interest included OR personnel’s awareness of surgical smoke hazards and the preventative measures in place to limit their exposure. Secondary outcomes included institutional policies and hazard education for the at-risk population. Data extraction and risk of bias assessments were performed independently by two reviewers. Results: From 3,194 articles, 27 full-text articles were reviewed, resulting in the inclusion of 10 studies comprising 4,409 OR personnel responses from seven different countries. More perioperative nurses were surveyed than any other OR personnel. Significant disparities were found in awareness and protective measures. Perioperative nurses demonstrated higher awareness than surgeons and anesthetists, who exhibited lower awareness and inconsistent use of protective measures. Hazard education was the primary predictor for surgical smoke hazard awareness and protective equipment usage. The evident exclusion of trainees, such as medical students and residents, from included surveys underscores a notable gap in research for personnel at risk of future exposure to the occupational hazards of surgical smoke. Discussion: This review demonstrates substantial variability in awareness and protective practices regarding surgical smoke among OR personnel. Perioperative nurses consistently exhibited greater awareness than surgeons and anesthetists, who, despite higher direct exposure, reported lower knowledge and inconsistent use of protective measures. The exclusion of trainees represents a critical deficiency, as early education is vital for fostering safe, long-term practices. Conclusion: These findings underscore the need for standardized training programs and comprehensive institutional policies to improve awareness and ensure consistent adoption of protective measures. Enhanced safety protocols are essential to safeguard OR personnel and ultimately improve patient care outcomes.
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 1 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
Supplemantary Video 1, LLC1 cells cocultured with NG2+ BMSCs
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 1 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
Supplemantary Video 1, LLC1 cells cocultured with NG2+ BMSCs
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 2 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
Supplemantary Video 2, LLC1 cells under monoculture
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 2 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
Supplemantary Video 2, LLC1 cells under monoculture
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 4 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
Supplemantary Video 4, LLC1 cells cocultured with NG2+ Ncadherin KO BMSCs
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 4 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
Supplemantary Video 4, LLC1 cells cocultured with NG2+ Ncadherin KO BMSCs
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Raw Data from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
Summarized excel file containing the quantitative raw data and processed values in the manuscript
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Raw Data from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells
Summarized excel file containing the quantitative raw data and processed values in the manuscript